Research Labs

The Kushal Dey lab focuses on developing machine learning models and computational pipelines that integrate genomic and epigenomic data.

Our team is focused on developing novel tools and approaches for the diagnosis and treatment of cancer using genomics as a guide.

The Diehl lab studies how the microbiota and other exogenous factors regulate development and function of the intestinal immune system.

The Diver lab studies the physiological roles and molecular mechanisms of understudied membrane-embedded proteins with the goal of revealing novel therapeutic targets for diseases such as pain and cancer.

Dr. Ahmet Dogan is a board-certified pathologist and an internationally recognized leader in hematopathology. His current research interests include lymphoma, plasma cell disorders, and diagnostic techniques for hematopathology such as cytogenetic analysis, genomics, and proteomics. His previous work has contributed much to the understanding of the histogenesis of lymphomas, MALT lymphomas, and T cell lymphomas in particular.

We leverage large-scale unbiased profiling including genomics, transcriptomics, proteomics to identify candidate oncogenes and proteins that are pathogenetically relevant in lymphoma.

Physician-scientist James Fagin focuses on the pathogenesis of thyroid cancer and the role of oncogenic kinases.

Lydia Finley studies the mechanisms that link metabolic pathways to cell fate decisions.

Cell biologist Timothy Ryan studies the molecular basis of synaptic transmission in the mammalian brain.

Cell biologist Hironori Funabiki focuses on regulation of the structure and configuration of chromosomes during the cell division cycle.